Nara Organics Infant Formula Recall: 3 Babies Hospitalized, 16 Lots Pulled, Second Botulism Outbreak in Eight Months

Three infants in three different states were hospitalized this spring after being fed a powdered organic formula their parents believed was safe. On June 13, 2026, the Food and Drug Administration announced that Nara Organics had agreed to recall every single lot of its Nara Organics Whole Milk Organic Powdered Infant Formula, sold nationally at Target stores, on Target.com, and directly through Nara.com. The reason was as serious as it gets in infant nutrition: possible contamination with Clostridium botulinum, the bacterium that causes infant botulism, a rare but potentially fatal paralytic illness. What makes this recall harder to accept is not just the diagnosis. It is the calendar. This is the second infant formula recall tied to botulism in less than a year, and the FDA had already told the public, in writing, that the retail supply chain failed to move fast enough the first time. Parents were told to trust the system again. The record raises a legitimate question about whether that trust is earned.

A national recall reaches into Alabama kitchens

Nara Organics is headquartered in New York, but its formula was not a regional product. According to the FDA's recall notice, the affected cans were distributed nationwide through Target's retail stores and website, as well as directly through the company's own site, from July 2025 through June 2026. Any household in Alabama that shops at Target, whether in Selma, Montgomery, Birmingham, or online, was within the distribution footprint of this product. This was not a niche boutique brand sold in a handful of specialty stores. It reached ordinary grocery carts in ordinary towns.

The exact timeline: how the recall unfolded

The confirmed facts, as reported by the FDA and the Centers for Disease Control and Prevention, lay out a specific sequence. The three infants involved in this outbreak became ill between April and May 2026, according to the FDA's outbreak investigation page. State and federal health officials identified the cluster and began coordinating an investigation with the CDC's Infant Botulism Treatment and Prevention Program. On June 13, 2026, the FDA contacted Nara Organics directly, and the company agreed to a voluntary recall of all lots, both can sizes, and all products sold under the Nara Organics infant formula label. The CDC issued its own public outbreak notice the same day, confirming three cases across California, Pennsylvania, and Washington state, all resulting in hospitalization, with no deaths reported as of the announcement.

That is the confirmed timeline. It is worth being explicit about what is not yet confirmed. As of the FDA's own reporting, testing of collected formula samples, both opened cans retained by families and unopened cans pulled from retail shelves, was still underway, with results expected in the coming weeks. No lot had tested positive for Clostridium botulinum contamination at the time these government notices were published. The FDA has stated the formula was manufactured in Europe and that a botulinum toxin type A infection was identified in the affected infants, but the specific point of contamination inside the supply chain remains under investigation. Parents deserve to know the difference between what regulators have proven and what they are still trying to prove, and right now, the source of contamination is the latter.

What was recalled: lots, sizes, and where it was sold

The recall covers all lots of Nara Organics Whole Milk Organic Powdered Infant Formula, sold in two can sizes with the following UPC codes, according to the FDA notice: the 700 gram can under UPC 860013251901, and the 400 gram can under UPC 860013251918. Sixteen separate lot codes were named in the recall, spanning production dates that stretched across nearly the entire distribution period. The company's recall notice directs consumers to check every can in their home against the full lot list posted on Nara.com and the FDA's own recall page, since even unopened, unused cans purchased months apart may fall under different lot numbers.

The product was sold exclusively in the United States. Families who purchased it directly from Nara.com between May and June 2026 are being issued automatic refunds, according to reporting from CBS News. Consumers who purchased the formula through Target, in store or online, are directed to Target's standard return process. Anyone with an opened can that matches a recalled lot is being told by the CDC not to discard it immediately, but to label it "DO NOT USE," photograph the lot code, and retain it in case public health investigators need it for testing.

Three hospitalized infants: what is confirmed, and what is not

The CDC's outbreak notice confirms that all three affected infants were between two and five months old when symptoms began. All three were hospitalized. All three received BabyBIG, the FDA-approved Botulism Immune Globulin Intravenous treatment reserved for infant botulism cases, and as of the public reporting, all three survived. No deaths have been reported in this outbreak. That is meaningful, confirmed good news, and this firm will not overstate the severity of an outcome that, so far, has not included a fatality.

What is also confirmed is the symptom pattern regulators are asking parents to watch for. The CDC and FDA describe constipation as frequently the first sign, followed by poor feeding, loss of head control, difficulty swallowing, and a noticeably decreased facial expression. CBS News reporting on the same outbreak added that treating physicians also observed drooping eyelids, sluggish pupil response, low muscle tone, a weak or altered cry, difficulty breathing, and generalized weakness in the hospitalized infants. Because infant botulism symptoms can take days to weeks to appear after exposure, the CDC has specifically instructed families who used the recalled formula to monitor their infants for a full month after the last time it was fed to them, even if the child currently appears healthy.

What is not yet confirmed is precisely how the contamination occurred, whether it originated at the manufacturing facility in Europe, in a specific ingredient, in packaging, or somewhere else in the supply chain. The FDA has been direct that this piece of the investigation is ongoing. This distinction matters. A family should never have to guess whether an official statement is a proven fact or a working theory, and this firm intends to keep that line clear throughout this case.

A second outbreak in under a year raises a harder question

Here is the fact that turns this from an isolated incident into a pattern worth scrutinizing. This is not the first time in recent memory that a national infant formula brand has been linked to a botulism outbreak. According to the FDA's own outbreak investigation page, an earlier outbreak tied to ByHeart Whole Nutrition Infant Formula resulted in 48 total illnesses nationwide, 28 confirmed and 20 probable, every one of them requiring hospitalization, across seventeen states, with infants ranging from 16 days to 264 days old. That outbreak's first reported illness onset was August 9, 2025, and the last was November 29, 2025. ByHeart's recall began on November 8, 2025, with two lots, and was expanded to the company's entire product line on November 11, 2025. The CDC formally declared that outbreak over on February 26, 2026, less than four months before the Nara Organics recall was announced.

Two national brands. Two botulism outbreaks. Fifty one hospitalized infants combined, by government count, across a span of roughly ten months. That is not speculation. Those numbers come directly from FDA and CDC outbreak pages. What this firm will not claim is that the two outbreaks share a common cause, a common ingredient supplier, or a common manufacturing failure. No government source has said that, and neither will we. What can be said, plainly, is that American parents were asked to trust the safety of powdered infant formula twice within less than a year, and twice, that trust was tested by a preventable, government confirmed illness in newborns and infants.

What the FDA already knows about recall enforcement gaps

This is the part of the story that should concern every parent, not just those who bought Nara Organics formula. In the aftermath of the ByHeart outbreak, the FDA did not simply close the investigation and move on. According to the FDA's own December 2025 press announcement and reporting by NPR, federal investigators found that recalled ByHeart formula remained on store shelves for more than three weeks after the recall began, discovered across more than 175 store locations in 36 states. NPR's reporting, citing FDA findings, specifically identified Target as one of the retailers where recalled formula was found in twenty states well after the recall was initiated, including one New Hampshire store that sold a recalled can on November 16, 2025, despite an electronic sales block that should have stopped the transaction, and an Arkansas location that was still advertising the recalled formula with a discount sign between November 16 and November 22, 2025. Walmart, Albertsons, and Kroger locations were also cited for shelving recalled product weeks after notification, according to the same reporting.

In response, the FDA sent warning letters to major retailers, conducted more than 4,000 retail store inspections to verify recall compliance, and gave retailers fifteen working days to respond with corrective action or a legal justification for noncompliance. FDA Commissioner Marty Makary was quoted stating that "food safety is a shared responsibility, and it is of utmost importance that all parties in the supply chain act swiftly and vigilantly."

To be precise and fair about what this firm knows and does not know: no government source has stated that Target, or any other retailer, failed to promptly pull the recalled Nara Organics formula from shelves in June 2026. That is an open question, not an established fact, and this firm will not assert otherwise. What is an established fact, sourced to the FDA and to NPR's reporting on that agency's own findings, is that the same major retail chain sat at the center of a documented recall enforcement failure only seven months before it became, once again, the primary retail channel for a national infant formula brand now linked to a second botulism outbreak. Parents are entitled to ask whether the lessons of the first outbreak were actually applied before the second one reached store shelves.

What parents and caregivers should do right now

If your infant was fed Nara Organics Whole Milk Organic Powdered Infant Formula at any point, the CDC's guidance is specific and should be followed immediately. Stop using the product. Check any cans in your home against the full lot list published by the FDA and by Nara Organics. If a can is unopened, the FDA and the company recommend discarding it or returning it through Target or Nara.com for a refund. If a can is opened, do not throw it away; label it "DO NOT USE," photograph the lot code clearly, and store it separately in case state health investigators need it for testing.

Because symptoms of infant botulism can take days or weeks to appear, the CDC has told parents to monitor their infant for a full month after the last time the recalled formula was used, even if the baby currently shows no signs of illness. Watch specifically for constipation, poor feeding, loss of head control, difficulty swallowing, a weakened or altered cry, drooping eyelids, or a noticeable loss of muscle tone. If any of these symptoms appear, the CDC's guidance is to seek emergency medical care immediately and to tell the treating physician that the infant was fed recalled Nara Organics formula. Treating physicians can also contact the Infant Botulism Treatment and Prevention Program directly for consultation, and government guidance instructs providers to begin BabyBIG treatment without waiting for laboratory confirmation, given how time sensitive treatment for this illness can be.

What should happen next: the accountability parents deserve

Two national infant formula outbreaks tied to the same bacterial illness within less than a year is not simply bad luck. It is a pattern that deserves a transparent, public accounting, not a quiet resolution behind closed doors. Parents deserve to know exactly where the contamination in the Nara Organics formula originated once testing is complete. They deserve to know whether every retailer that sold the recalled product, including Target, removed it from shelves and disabled sales as quickly as the FDA's own post-ByHeart guidance demanded. And they deserve a formula supply chain, manufacturer, and retail industry that treats a documented enforcement failure as a lesson learned rather than a box checked.

This firm believes that when a family trusts a product intended for the most vulnerable member of their household, that trust should be met with real accountability, not a refund form and a press release. If your infant became ill after being fed Nara Organics formula, or any recalled infant formula product, you should not have to navigate the medical, emotional, and legal aftermath alone while waiting for federal investigators to finish their work.

Frequently asked questions

Was the Nara Organics infant formula recall confirmed by the FDA?

Yes. The FDA announced on June 13, 2026 that Nara Organics agreed to a voluntary recall of all lots of its Whole Milk Organic Powdered Infant Formula after being contacted by federal investigators regarding a cluster of infant botulism cases. The CDC issued a corresponding public outbreak notice the same day.

How many infants have been confirmed sick in this outbreak?

As of the FDA and CDC's public reporting, three infants across California, Pennsylvania, and Washington state were hospitalized with infant botulism linked to this formula. All three were treated with BabyBIG, and no deaths have been reported.

Has the FDA confirmed exactly how the formula became contaminated?

No. As of the government notices reviewed for this article, testing of retained and shelf formula samples was still underway, with results expected in coming weeks. The FDA has stated the formula was manufactured in Europe and that a botulinum toxin type A infection was found in the affected infants, but the precise source of contamination in the supply chain had not been confirmed publicly.

Is this the first time an infant formula brand has been linked to a botulism outbreak recently?

No. According to the FDA's own outbreak investigation records, ByHeart Whole Nutrition Infant Formula was linked to a separate botulism outbreak that sickened 48 infants across seventeen states between August and November 2025, with that outbreak formally declared over by the CDC on February 26, 2026, roughly four months before the Nara Organics recall was announced.

What should I do if I still have Nara Organics formula in my home?

Stop using it immediately. Check the lot code against the FDA's published recall list. Unopened cans should be discarded or returned for a refund through Target or Nara.com. Opened cans should be labeled "DO NOT USE," photographed, and retained in case health investigators request them for testing, per CDC guidance.

My baby was fed this formula and later developed symptoms. What should I do?

Seek emergency medical attention immediately and tell the treating physician that your infant consumed recalled Nara Organics formula, since prompt treatment with BabyBIG is time sensitive. Once your child is medically stable, contact the Law Offices of Elliott Owen Lipinsky to discuss what happened and what options may be available to your family.

No parent should have to relive a government recall notice while sitting in a hospital room with their infant. If your baby was hospitalized, treated, or harmed after being fed Nara Organics infant formula, or any other recalled infant formula product, the Law Offices of Elliott Owen Lipinsky in Selma, Alabama wants to hear what happened to your family. We believe Alabama families deserve real answers about how a contaminated product reached their kitchen, and real accountability from the companies and retailers responsible for keeping it there. Call (334) 230-7986 to speak with our office about your family's situation. There is no cost to have that conversation.